Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula
NCT ID: NCT01573871
Last Updated: 2013-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
25 participants
INTERVENTIONAL
2012-02-29
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolerance of Infants Fed a Hydrolysate Formula
NCT03628183
Infants Fed a Hydrolyzed Infant Formula
NCT05369494
Tolerance of Healthy Term Infants Fed Infant Formulas #4
NCT01155414
Formula Tolerance of Term Infants
NCT04915937
Tolerance of Healthy Term Infants Fed Infant Formulas
NCT00705562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hydrolyzed infant formula
Hydrolyzed infant formula to be fed ad libitum
Experimental Hydrolyzed infant formula
Experimental hydrolyzed infant formula to be fed ad libitum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental Hydrolyzed infant formula
Experimental hydrolyzed infant formula to be fed ad libitum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infant with persistent feeding intolerance symptoms; has had at least 1 formula switch OR infant is experiencing/being managed with an extensively hydrolyzed formula for suspected food protein intolerance or allergy or other condition where an extensively hydrolyzed formula is deemed appropriate
* Infant has not consumed an extensively hydrolyzed infant formula
* Use of prescription medications, OTC medications, home remedies, herbal preparations or rehydration fluids restricted
* Infant is not receiving steroids.
* Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study
* Parent(s) confirm their intention not to administer solid foods or juices to their infant through the duration of the study.
* Parent(s) confirm their intention not to administer vitamin or mineral during the study
Exclusion Criteria
180 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlene Borschel, PhD
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northpoint Pediatrics
Indianapolis, Indiana, United States
Metro-Health Medical Center
Cleveland, Ohio, United States
Ohio Pediatric Research Association
Huber Heights, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AK94
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.